More information: Xiao Ling et al, Identification of CT based radiomic biomarkers for progression free survival in head and ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during ...

Uppaluri will then present the study in Clinical Trials Plenary Session CT001 on Sunday, April 27, 2025, from 2:00-2:15 p.m. ET / 1:00-1:15 p.m. CT. Douglas Adkins, MD, professor of medicine and ...